[Oncofetal proteins - their character and clinical significance as tumour-markers (author's transl)].
Substances with tumour-marker functions were characterized in the present review. Based on detailed knowledge available for the oncofetal proteins AFP and CEA conclusions were drawn in respect to the present position and future development for this group of substances.
D000951:Antigens, Neoplasm / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D003937:Diagnosis, Differential; D006801:Humans; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000097:blood; D009369:Neoplasms / Q000097:blood* / Q000175:diagnosis; D011379:Prognosis; D000509:alpha-Fetoproteins / Q000032:analysis*
D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D000509:alpha-Fetoproteins
Onkofetale Proteine - Eigenschaften und klinische Bedeutung als Tumor- Marker.